Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The company has has 10 existing labs in India
It’s a two-dose vaccine administered 28 days apart
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Subscribe To Our Newsletter & Stay Updated
